pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioPharma Dive·Jul 27·1 min read
save

Almac Clinical Services podcast details end-to-end clinical trial supply chain

Jul 27, 2026·read at BioPharma Dive ↗Neutral

Almac Clinical Services released a six-part podcast that walks listeners through the clinical trial supply chain from protocol planning to patient delivery. The series, published by BioPharma Dive’s studio, was first released on July 12, 2026 and updated on May 26, 2026.

The early episodes explain how investigators develop supply strategies and design trial kits that fit patients’ daily lives, ensuring the medicines are ready before any site opens.

Later episodes focus on the complexities of global drug distribution, including last-mile logistics, product integrity, and the link between quality controls and trial timelines. The discussion highlights how these factors affect patient safety.

All five episodes are available online, and the content is presented as sponsored material from Almac Clinical Services.

source

This writeup was produced by pharmadog from original reporting by BioPharma Dive.

Original headline: “[Podcast] From Protocol to Patient: Inside Clinical Supply with Almac Clinical Services”

read at BioPharma Dive ↗
380 words · retrieved Jul 12
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
JOURNEYThe Medicines Co

related stories

  • Jul 17Compounders maintain a firm grip on the GLP-1 marketBioPharma Dive
  • Jul 16US drug shortages rise for third straight quarter, hurt by lone suppliersEndpoints
  • Jul 15STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and moreSTAT
  • Jun 30STAT+: All of Us tests a new approach to collect real-world data for researchSTAT
  • Jun 25De-Risking a Rare Disease Launch Starts with PrecisionFierce Biotech